Flo Health, recognized as the top downloaded women’s health app globally, has achieved a milestone by attaining unicorn status. As of June 2024, the app supports nearly 70 million monthly active users (MAUs) and boasts close to 5 million paid subscribers. Offering comprehensive support from menstruation through to menopause, Flo Health provides cycle and ovulation tracking, personalized health insights, daily visual content, and a secure community for users to connect.
Eric Crowley, Partner at GP Bullhound, emphasized the significance of Flo Health’s achievement within the femtech sector, describing it as a landmark deal that underscores the app’s unique position in digital women’s health. Crowley expressed confidence in Flo Health’s trajectory, citing their innovative approach to revolutionizing women’s health globally.
Flo Health’s co-founder and CEO, Dmitry Gurski, highlighted the company’s journey from identifying gaps in women’s health services to becoming a leader in the global femtech movement. Their commitment includes a pro-social initiative that grants free access to Flo Premium across 66 countries, benefiting nearly 1.2 million women. Gurski outlined their vision to reach 1 billion women, ensuring inclusivity and support regardless of geographic or economic barriers.
Anna Klepchukova, Chief Medical Officer of Flo Health, emphasized the app’s role in addressing disparities in women’s health, aiming to improve health outcomes significantly.
Recognized for its commitment to privacy and trust, Flo Health’s Anonymous Mode feature received accolades from TIME and Fast Company, further validating its role as a reliable source of digital health information.
With a strategic investment from General Atlantic, Flo Health plans to accelerate growth by expanding into new user segments, enhancing technological capabilities, and broadening its global footprint. This partnership marks a pivotal moment for Flo Health as they continue to drive conversations, improve health literacy, and raise awareness of women’s health issues worldwide.